Corey Allen Mcclary

Corey * specializes in intellectual property law. With a Ph.D. in organic chemistry and experience litigating a broad range of complex matters in the pharmaceutical and life sciences industries, Corey brings his technical expertise, unique perspective, and positive attitude to every case he works on. Whether it's synthesizing scientific concepts into clear and concise language for the courts or developing novel legal strategies, Corey knows § how to innovate and leverage his creativity and depth of knowledge to overcome challenges and develop winning strategies for his clients. You can count on Corey to know what it takes ‡ to deliver the best results. .

Corey's practice is primarily focused on intellectual property law, with an emphasis on pharmaceutical patent litigation. Corey has experience advising clients on complex disputes, including actions under the Patented Medicines (Notice of Compliance) Regulations , patent infringement and impeachment actions, and judicial review proceedings. Corey also regularly provides strategic patent and regulatory advice.

Prior to joining Lenczner Slaght, Corey summered, articled and practiced in the intellectual property litigation group at a leading international law firm in Toronto.

Before attending law school, Corey obtained a Ph.D. in organic chemistry. His graduate research focused on developing methods for the regioselective functionalization of carbohydrates and measuring the strength of non-covalent interactions. His research has been published in peer-reviewed scientific journals.

Genentech Inc and Hoffmann-La Roche Limited v Biosimilar Collaborations Ireland Limited

Counsel to Genentech Inc and Hoffmann-La Roche Limited, global pharmaceutical and biotechnology companies, in bringing a PM(NOC) action in the Federal Court involving Canadian Patent Nos. 2,788,253 and 2,711,798.